Clinically active Crohn's disease in the presence of a low C-reactive protein

References

• Clos TD, Mold C. The role of C-reactive protein in the resolution of bacterial infection. Curr Opin Infect Dis 2001; 14: 289–93
   PubMed Web of Science ®Google Scholar
• Darlington G, Wilson D, Lachman L. Monocyte-conditioned medium, interleukin-1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro. J Cell Biol 1986; 103: 787–93
   PubMed Web of Science ®Google Scholar
• Best W, Becktel J, Singleton J, Kern F., Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 439–44
   PubMed Web of Science ®Google Scholar
• Goebell H, Wienbeck M, Schomerus H, Malchow H. Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study. Med Klin (Munich) 1990; 85: 573–6
   PubMedGoogle Scholar
• Gomes P, Boulau CD, Smith C, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 92–5
   PubMed Web of Science ®Google Scholar
• Cellier C, Sahmoud T, Froguel E, Adenis A, Belaiche J, Bretagne J, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994; 35: 231–5
   PubMed Web of Science ®Google Scholar
• Schreiber S, Fedorak R, Rutgeerts P, Innes A, Patel J. CDP870, a pegylated humanised anti-TNF antibody fragment, offers particular benefit to Crohn's disease patients with elevated C-reactive protein. Gut ; S6 2003; 52: A4
   Google Scholar
• Rutgeerts P, Colombel J, Enns R, Feagan B, Hanauer S, Lawrence I, et al. Subanalyses from a phase 3 study on the evaluation of natalizumab in active Crohn's disease (ENACT-1). Gut ; S6 2003; 52: A239
   Google Scholar
• Targan S, Hanauer S, van Deventer S, Mayer L, Present D, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029–35
   PubMed Web of Science ®Google Scholar
• Louis E, Vermeire S, Rutgeerts P, Vos MD, Gossum AV, Pescatore P, et al. A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with (308 TNF gene polymorphism. Scand J Gastroenterol 2002; 37: 818–24
   PubMed Web of Science ®Google Scholar
• Lennard-Jones J. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170 Suppl: 2–6
   Web of Science ®Google Scholar
• Gasche C, Alizadeh B, Pena A. Genotype-phenotype correlations: how many disorders constitute inflammatory bowel disease?. Eur J Gastroenterol Hepatol 2003; 15: 599–606
   PubMed Web of Science ®Google Scholar
• Hugot J, Chamaillard M, Zouali H, Lesage S, Cezard J, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen D, Inohara N, Nicolae D, Chen F, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Cavanaugh J, Adams K, Quak E, Bryce M, O'Callaghan N, Rodgers H, et al. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet 2003; 67: 35–41
   PubMed Web of Science ®Google Scholar
• Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms. Gut 1992; 33: 331–5
   PubMed Web of Science ®Google Scholar
• Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244–50
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Berlin JA, Lichtenstein GR. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology 1998; 115: 259–67
   PubMed Web of Science ®Google Scholar
• Borley NR, Mortensen NJ, Chaudry MA, Mohammed S, Warren BF, Geoghan BD, et al. Recurrence after abdominal surgery for Crohn's disease: relationship to disease site and surgical procedure. Dis Colon Rectum 2002; 45: 377–83
   PubMed Web of Science ®Google Scholar
• Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002; 122: 854–66
   PubMed Web of Science ®Google Scholar
• Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype–phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845–57
   PubMed Web of Science ®Google Scholar
• Greenfield J, Samaras K, Jenkins A, Kelly P, Spector T, Gallimore J, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004; 109: 3022–8
   PubMed Web of Science ®Google Scholar
• Maachi M, Pieroni L, Bruckert E, Jardel C, Fellahi S, Hainque B, et al. Systemic low-grade inflammation is related to both circulating and adipose tissue TNFalpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord 2004; 28: 993–7
   PubMed Web of Science ®Google Scholar
• Williams M, Williams S, Milne B, Hancox R, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Int J Obes Relat Metab Disord 2004; 28: 998–1003
   PubMed Web of Science ®Google Scholar
• Desreumaux P, Ernst O, Geboes K, Gambiez L, Berrebi D, Muller-Alouf H, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999; 117: 73–81
   PubMed Web of Science ®Google Scholar
• Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, AF., Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–808
   PubMed Web of Science ®Google Scholar
• Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn's disease clinical course and severity in obese patients. Clin Nutr 2002; 21: 51–7
   PubMed Web of Science ®Google Scholar
• Smedh K, Olaison G, Nystrom P, Sjodahl R. Intraoperative enteroscopy in Crohn's disease. Br J Surg 1993; 80: 897–900
   PubMed Web of Science ®Google Scholar
• Sheehan A, Warren B, Gear M, Shepherd N. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992; 79: 955–8
   PubMed Web of Science ®Google Scholar
• Borley N, Mortensen N, Jewell D, Warren B. The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causal link. J Pathol 2000; 190: 196–202
   PubMed Web of Science ®Google Scholar